Related Experiment Video
Updated: Jun 10, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Integrated Analysis of Multi-Omic Data Reveals Regulatory Mechanisms and Network Characteristics in Breast Cancer
Zahra Hosseinpour1, Mostafa Rezaei Tavirani2, Mohammad Esmaeil Akbari3
1Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background:
Breast cancer is a complex and heterogeneous disease, and understanding its regulatory mechanisms and network characteristics is essential for identifying therapeutic targets and developing effective treatment strategies. This study aimed to unravel the intricate network of interactions involving differentially expressed genes, microribonucleic acid (miRNAs), and proteins in breast cancer through an integrative analysis of multi-omic data from Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) dataset.
Methods:
The TCGA-BRCA dataset was used for data acquisition, which included RNA sequencing data for gene expression, miRNA sequencing data for miRNA expression, and protein expression quantification data. Various R packages, such as TCGAbiolinks, limma, and RPPA, were employed for data preprocessing and integration. Differential expression analysis, network construction, miRNA regulation exploration, pathway enrichment analysis, and independent dataset validation were performed.
Results:
Eight consistently upregulated hub genes-including ACTB, HSP90AA1, FN1, HSPA8, CDC42, CDH1, UBC, and EP300-were identified in breast cancer, indicating their potential significance in driving the disease. Pathway enrichment analysis revealed highly enriched pathways in breast cancer, including proteoglycans in cancer, PI3K-Akt, and mitogen-activated protein kinase signaling.
Conclusion:
This integrated multi-omic data analysis provides valuable insights into the regulatory mechanisms, network characteristics, and functional roles of genes, miRNAs, and proteins in breast cancer. The findings contribute to our understanding of the molecular landscape of breast cancer, facilitate the identification of potential therapeutic targets, and inform strategies for effective treatment.
Insights
This study identified eight key upregulated genes in breast cancer by analyzing multi-omic data. These findings offer insights into breast cancer
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Bioinformatics
Background:
- Breast cancer is a complex disease requiring understanding of its regulatory networks.
- Identifying therapeutic targets necessitates knowledge of gene, miRNA, and protein interactions.
- Multi-omic data integration is crucial for unraveling disease mechanisms.
Purpose of the Study:
- To investigate the interaction network of differentially expressed genes, miRNAs, and proteins in breast cancer.
- To identify potential therapeutic targets through integrative analysis of multi-omic data.
- To understand the regulatory mechanisms and network characteristics of breast cancer.
Main Methods:
- Utilized the Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) dataset.
- Performed integrated analysis of RNA sequencing, miRNA sequencing, and protein quantification data.
- Employed differential expression analysis, network construction, and pathway enrichment analysis.
Main Results:
- Identified eight consistently upregulated hub genes: ACTB, HSP90AA1, FN1, HSPA8, CDC42, CDH1, UBC, and EP300.
- Discovered enriched pathways including 'proteoglycans in cancer', 'PI3K-Akt signaling', and 'mitogen-activated protein kinase signaling'.
- Established potential significance of identified genes in driving breast cancer progression.
Conclusions:
- Integrated multi-omic analysis provides insights into breast cancer regulatory networks.
- Findings facilitate the identification of novel therapeutic targets.
- Contributes to a deeper understanding of breast cancer's molecular landscape and treatment strategies.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Genomics
Cancer Survival Analysis

